By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Wockhardt Towers
Bandra-Kurla Complex
Mumbai    400 051  India
Phone: 91-22-2653-4444 Fax: 91-22-2653-4242


Company News
Wockhardt (WOCKHARDT.BO)'s Antibiotic Injection Gets U.S. FDA Approval 8/7/2017 7:34:16 AM
Wockhardt (WOCKHARDT.BO) Receives Acknowledgement Of Its Breakthrough Superdrug Antibiotic WCK 5222 For Phase III Clinical Trial From US FDA 4/4/2017 6:39:16 AM
FDA Issues Warning Letter To Wockhardt (WOCKHARDT.BO)’s Ankleshwar Plant 1/9/2017 7:50:07 AM
Wockhardt (WOCKHARDT.BO) Introduces LabHQ LIMS For Quality Control 11/11/2016 10:25:42 AM
Wockhardt (WOCKHARDT.BO) Plunges On U.S. Ban On Third Drug-Making Factory 8/8/2016 6:14:24 AM
FDA Discovers Wockhardt (WOCKHARDT.BO) Hid Failed Tests and Deleted Data at Indian Plant 1/29/2016 6:22:55 AM
Wockhardt (WOCKHARDT.BO) Receives ANDA Approval For Pain Medication Oxycodone Liquid 6/22/2015 6:38:13 AM
U.S. FDA Grants QIDP Status For Wockhardt (WOCKHARDT.BO) Anti-Infective Drug Discovery Program 9/2/2014 12:55:00 PM
FDA Cites Manufacturing Concerns At Wockhardt (WOCKHARDT.BO)'s U.S. Unit 5/28/2014 7:17:46 AM
Wockhardt (WOCKHARDT.BO) Falls 4%, FDA Says Company Erased Key Trial Data 12/4/2013 7:53:53 AM